Try our Advanced Search for more refined results
February 09, 2018
Giugno v. Bristol-Myers Squibb Company et al
Case Number:
3:18-cv-00878
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Adamski Moroski
- Bernstein Litowitz
- Glancy Prongay
- Grant & Eisenhofer
- Kirkland & Ellis
- Pomerantz LLP
- Saxena White
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 12, 2018
Bristol-Myers Oversold Lung Cancer Drug, Investors Say
Bristol-Myers Squibb Co. was slapped with a putative class action in California federal court on Friday, alleging company officials deceived investors about the prospects for its lung cancer drug, which resulted in artificially inflated company stock prices that plunged when the therapy failed its clinical trial.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login